Pascal Neuville

Pascal Neuville is a French biochemist and business executive who has held various positions in the pharmaceutical and biotech industries. Pascal is currently the director of Ermium Therapeutics, a French biotech company.

Neuville began their career as a project leader at Transgene, a French biotech company, in 1999. Pascal held this position for three years before moving to Faust Pharmaceuticals, where they served as chief scientific officer for six years. In 2008, they became the chairman of the board of BioValley, a French life sciences cluster organization. Pascal held this position for two years before moving to Domain Therapeutics, a French biotech company, in 2010.

In 2012, Neuville joined the Strategic Committee of the Excellence Initiative at Université de Strasbourg. Pascal held this position for four years before moving to their current position as director at Ermium Therapeutics in 2016.

Pascal Neuville's educational career includes a PhD in Mol & Cell Biology from the University of Strasbourg and research in the field of Retinoids and smooth muscle cells/restenosis/fibrosis at the University of Geneva.